Cancer care is changing  and with GEMINI-RT, radiation therapy might just leap into a new era. Announced jointly by GE HealthCare and Mayo Clinic, GEMINI-RT is a bold research collaboration that seeks nothing less than to personalise radiation treatment for each patient. The idea “twin the patient, personalise the beam.” 

Traditionally, radiation therapy planning involves a set workflow  imaging, treatment planning, dosimetry, and delivery. GEMINI-RT aims to shake that up by layering on advanced imaging technologies, AI-driven planning tools, adaptive dosimetry, and continuous patient monitoring  all stitched together into a seamless, data-driven care pathway from diagnosis through follow-up. 

At the heart of the initiative are four pillars

Automation  AI-powered solutions will trim down repetitive tasks, speeding up treatment planning and freeing up clinicians’ time.
Predictive Oncology  Using patient data and advanced analytics to help tailor therapy based on individual risk, tumour biology, and expected response.
Multi-modal Therapies  Combining radiation with other emerging treatments (targeted drugs, precision heating) for better effectiveness.
Connected Care & Monitoring  Extending care beyond the clinic: using sensors, biomarkers, and remote monitoring to track patient health and catch side-effects early. 

This isn’t a modest pilot  GEMINI-RT builds on a long-standing collaboration (a 2023 radiology research alliance between the two) and signals a major push toward transforming global cancer care infrastructure. 

If successful, this could mean faster treatment planning, better-tailored radiation doses, fewer side-effects, and more responsive care even after patients return home. For clinicians, it could reduce burnout and streamline workflows. For patients, it promises a future where radiation therapy isn’t one-size-fits-all  but uniquely theirs.